Global Scans · Genetics · Weekly Summary

• [New] CIAPM will support doctoral student research and build a cohort of approximately 15 early career researchers to develop the next generation of precision medicine leaders ($2 million for ~15 doctoral students). California Health & Human Services
• [New] Legal experts and national security analysts are increasingly warning that AI-generated deepfakes could become one of the most destabilizing forces in modern politics, raising urgent questions about election integrity, free speech protections, and the limits of U.S. law. USA Herald - The People's Voice
• [New] New research from the MIT Center for Information Systems Research can help business leaders take stock of the generative AI risk space - the set of components that introduce risk, including training data and user prompts. MIT Sloan
• [New] Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient's heart failure prognosis up to a year in advance. MIT News | Massachusetts Institute of Technology
• [New] Chief economists largely agree AI will generate meaningful productivity gains. metaintro
• [New] The future of generative art platforms beyond 2026 will be defined by five forces-hyper-personalized AI assistants, decentralized creative marketplaces, immersive mixed-reality creation, ethical data governance, and cross-platform interoperability. The Klay Studio
• [New] 30% of enterprises will abandon facial recognition due to deepfake vulnerabilities, while new regulations will mandate clear labeling of AI-generated content. vmblog.com
• [New] By 2029, AI agents are projected to generate 10 times more data from physical environments than from all digital AI applications combined. Gartner
• [New] OpenAI plans to add its Sora video generation model directly into ChatGPT, The Information reports. Engadget
• [New] Pakistani threat group APT36 adopted AI-assisted code generation (vibe-coding) to produce malware at scale. Tech Jacks Solutions
• [New] On the technology front, IonQ plans to demonstrate an operational 256-qubit sixth-generation quantum computer in 2026 while continuing deployments of its fifth-generation Tempo systems. Yahoo Finance
• [New] General vaccinations in Brazil are expected to increase, stemming from a strategic partnership between Brazil and China that involves the transfer of national technology to WuXi Vaccines. Vax-Before-Travel
• [New] Electricity generation is now the limiting factor in scaling AI, predicting China could outpace the US in total AI compute because of its faster energy build-out. Business Insider
• [New] Manufacturers generate astounding volumes of data; ABI Research projects that industrial enterprises globally will generate a total of 4.4 Zettabytes of data by 2030, up from 1.9 ZB in 2023. Industry Today - Leader in Manufacturing & Industry
• [New] The ACT Tech Trends report found that Deloitte's research shows 72% of insurance leaders expect generative AI to drive changes in their talent strategies, but the biggest barrier to adoption is finding people with the right technical skills. InsuranceIndustry.AI
• The TruPath Genome launch and Florida pediatric rare disease lab support deepen Illumina's rare disease footprint, but do not obviously change the near term focus on NovaSeq X utilization as a key catalyst or on research and China weakness as the most immediate risks. Yahoo Finance
• Even in wealthy nations, such as Australia, we saw that not using genetic techniques might lead to lower estimates of species richness. The Week
• As regulatory acceptance expands globally, CRISPR-based crop varieties are expected to enter commercial agriculture at a much faster pace. openpr
• Merlin CP-GEP is the only gene expression profile assay prospectively validated in a large, multi-center blinded trial to assess metastatic potential and SLN positivity risk. Cision PR Newswire
• Over the next five years, declining measles vaccination rates alone could cost an estimated $1.5 billion annually and generate approximately $7.8 billion in cumulative costs. / USA Alston & Bird
• ViiV Healthcare's investigational capsid inhibitor VH-499, ViiV's next generation integrase inhibitor VH-184 and Gilead Sciences' pipeline integrase inhibitor GS-3242 could potentially be administered by injection just twice a year. aidsmap.com

Last updated: 22 March 2026